{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T23:16:56Z","timestamp":1793575016475,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":14,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ero.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EULAR Rheumatology Open"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ero.2025.10.005","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T05:37:10Z","timestamp":1763703430000},"page":"380-393","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Interdisciplinary Clinical Practice Guidelines for patient-centred management of juvenile-onset systemic lupus erythematosus"],"prefix":"10.1016","volume":"1","author":[{"given":"Kirsten","family":"M\u00f6nkem\u00f6ller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz T.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"H\u00e4usler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilmann","family":"Kallinich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Benseler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermine I.","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Bieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Deuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Hedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claas","family":"Hinze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Hospach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike-Katharina","family":"Hoyer-Kuhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ales","family":"Janda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Kamitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Ae","family":"Lee-Kirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Neudorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Reichert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Aringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Schanze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolaus","family":"Schwerk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merle","family":"Seume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Speth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkhard","family":"T\u00f6nshoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3566-227X","authenticated-orcid":false,"given":"Klaus","family":"Tenbrock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Haffner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8731-8924","authenticated-orcid":false,"given":"Catharina","family":"Schuetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ero.2025.10.005_bib0001","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1016\/S0140-6736(19)30546-X","article-title":"Novel paradigms in systemic lupus erythematosus","volume":"393","author":"D\u00f6rner","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ero.2025.10.005_bib0002","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/acr.23319","article-title":"From childhood to adulthood: disease activity trajectories in childhood-onset systemic lupus erythematosus","volume":"70","author":"Lim","year":"2018","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.ero.2025.10.005_bib0003","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1177\/0961203316644333","article-title":"Differences in disease phenotype and severity in SLE across age groups","volume":"25","author":"Ambrose","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.ero.2025.10.005_bib0004","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/art.40697","article-title":"Long-term clinical outcomes in a cohort of adults with childhood-onset systemic lupus erythematosus","volume":"71","author":"Groot","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ero.2025.10.005_bib0005","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.semarthrit.2019.05.010","article-title":"Longitudinal disease- and steroid-related damage among adults with childhood-onset systemic lupus erythematosus","volume":"49","author":"Heshin-Bekenstein","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.ero.2025.10.005_bib0006","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000518321","article-title":"Differences in the clinical manifestations and mortality of systemic lupus erythematosus onset in children and adults: a systematic review and meta-analysis","volume":"183","author":"Huang","year":"2022","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.ero.2025.10.005_bib0007","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1177\/0961203315627202","article-title":"Overall and cause-specific mortality in systemic lupus erythematosus: an updated meta-analysis","volume":"25","author":"Lee","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.ero.2025.10.005_bib0008","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/acr.23834","article-title":"American College of Rheumatology provisional criteria for clinically relevant improvement in children and adolescents with childhood-onset systemic lupus erythematosus","volume":"71","author":"Brunner","year":"2019","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.ero.2025.10.005_bib0009","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/BOR.0000000000000913","article-title":"Current views on lupus in children","volume":"35","author":"Smith","year":"2023","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.ero.2025.10.005_bib0010","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1136\/annrheumdis-2016-210960","article-title":"European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative","volume":"76","author":"Groot","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ero.2025.10.005_bib0011","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/ard-2022-223328","article-title":"Towards development of treat to target (T2T) in childhood-onset systemic lupus erythematosus: PReS-endorsed overarching principles and points-to-consider from an international task force","volume":"82","author":"Smith","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ero.2025.10.005_bib0012","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s40272-021-00457-z","article-title":"An update on the management of childhood-onset systemic lupus erythematosus","volume":"23","author":"Trindade","year":"2021","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.ero.2025.10.005_bib0013","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"KDIGO 2021 Clinical Practice Guideline for the management of glomerular diseases","volume":"100","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.ero.2025.10.005_bib0014","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2023.09.002","article-title":"KDIGO 2024 Clinical Practice Guideline for the management of lupus nephritis","volume":"105","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.ero.2025.10.005_bib0015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/ard-2023-224762","article-title":"EULAR recommendations for the management of systemic lupus erythematosus: 2023 update","volume":"83","author":"Fanouriakis","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ero.2025.10.005_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2024.110214","article-title":"Defining remission in childhood-onset lupus: PReS-endorsed consensus definitions by an international task force","volume":"263","author":"Smith","year":"2024","journal-title":"Clin Immunol"},{"key":"10.1016\/j.ero.2025.10.005_bib0017","doi-asserted-by":"crossref","DOI":"10.1002\/acr2.11737","article-title":"Implementation of the lupus low disease activity state in pediatric rheumatology care: the role of the visual analog scale","volume":"7","author":"Ogbu","year":"2025","journal-title":"ACR Open Rheumatol"},{"key":"10.1016\/j.ero.2025.10.005_bib0018","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/acr.23531","article-title":"Measuring disease damage and its severity in childhood-onset systemic lupus erythematosus","volume":"70","author":"Holland","year":"2018","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.ero.2025.10.005_bib0019","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1024\/0040-5930\/a001382","article-title":"Shared decision-making in der p\u00e4diatrie [Shared decision-making in pediatrics - a collaborative process within the therapeutic triangle between parents, the child and professionals]","volume":"79","author":"Streuli","year":"2022","journal-title":"Ther Umsch"},{"key":"10.1016\/j.ero.2025.10.005_bib0020","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1007\/s00431-021-04055-6","article-title":"Chronically ill children\u2019s participation and health outcomes in shared decision-making: a scoping review","volume":"180","author":"Wijngaarde","year":"2021","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.ero.2025.10.005_bib0021","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ero.2025.10.005_bib0022","article-title":"Validation and optimization of classification criteria for childhood-onset systemic lupus erythematosus in a multi-center Chinese cohort","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.ero.2025.10.005_bib0023","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/annrheumdis-2016-209770","article-title":"EULAR recommendations for women\u2019s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome","volume":"76","author":"Andreoli","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ero.2025.10.005_bib0024","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.3928\/00904481-20150611-11","article-title":"Neuropsychiatric systemic lupus erythematosus in children","volume":"44","author":"Soybilgic","year":"2015","journal-title":"Pediatr Ann"},{"key":"10.1016\/j.ero.2025.10.005_bib0025","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S2352-4642(22)00157-2","article-title":"Neuropsychiatric manifestations in childhood-onset systemic lupus erythematosus","volume":"6","author":"Appenzeller","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.ero.2025.10.005_bib0026","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1177\/0961203307078971","article-title":"Neuropsychiatric involvement in pediatric systemic lupus erythematosus","volume":"16","author":"Benseler","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.ero.2025.10.005_bib0027","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ncl.2009.09.004","article-title":"Neurologic manifestations of systemic lupus erythematosus in children and adults","volume":"28","author":"Muscal","year":"2010","journal-title":"Neurol Clin"},{"key":"10.1016\/j.ero.2025.10.005_bib0028","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/RHU.0000000000001029","article-title":"Neuropsychiatric syndromes in childhood-onset systemic lupus erythematosus: a systematic review and meta-analysis","volume":"27","author":"Santos","year":"2021","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.ero.2025.10.005_bib0029","first-page":"748","article-title":"Infections associated with juvenile systemic lupus erythematosus","volume":"19","author":"Al-Mayouf","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ero.2025.10.005_bib0030","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S2352-4642(24)00172-X","article-title":"Childhood-onset systemic lupus erythematosus in China, 2016-21: a nationwide study","volume":"8","author":"Gao","year":"2024","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.ero.2025.10.005_bib0031","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.622326","article-title":"C-reactive protein levels in systemic lupus erythematosus are modulated by the interferon gene signature and CRP gene polymorphism rs1205","volume":"11","author":"Enocsson","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.ero.2025.10.005_bib0032","doi-asserted-by":"crossref","first-page":"5837","DOI":"10.3390\/jcm10245837","article-title":"The complex role of C-reactive protein in systemic lupus erythematosus","volume":"10","author":"Enocsson","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.ero.2025.10.005_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2024.110172","article-title":"First validation of the childhood lupus low disease activity state (cLLDAS) definition in a real-life longitudinal cSLE cohort","volume":"262","author":"Bergkamp","year":"2024","journal-title":"Clin Immunol"},{"key":"10.1016\/j.ero.2025.10.005_bib0034","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1007\/s10067-024-07101-4","article-title":"Active implementation of low disease activity state as a treatment endpoint in childhood-onset systemic lupus erythematosus in routine practice is both feasible and associated with better outcomes","volume":"43","author":"Gotch","year":"2024","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ero.2025.10.005_bib0035","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1136\/ard-2024-226392","article-title":"Correspondence on \u2018EULAR recommendations for the management of systemic lupus erythematosus: 2023 update\u2019 by Fanouriakis et al","volume":"83","author":"Roberts","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ero.2025.10.005_bib0036","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1056\/NEJMoa2410965","article-title":"Efficacy and safety of obinutuzumab in active lupus nephritis","volume":"392","author":"Furie","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ero.2025.10.005_bib0037","article-title":"New medicines for childhood-onset systemic lupus erythematosus: an EU perspective on paediatric drug development","volume":"12","author":"De Lisa","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ero.2025.10.005_bib0038","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s00393-020-00751-0","volume":"79","author":"Fiehn","year":"2020","journal-title":"Z Rheumatol"},{"key":"10.1016\/j.ero.2025.10.005_bib0039","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2024-001351","article-title":"Low versus high initial oral glucocorticoid dose for lupus nephritis: a pooled analysis of randomised controlled clinical trials","volume":"12","author":"Saxena","year":"2025","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.ero.2025.10.005_bib0040","first-page":"155","article-title":"Corticosteroid use in childhood-onset systemic lupus erythematosus-practice patterns at four pediatric rheumatology centers","volume":"27","author":"Brunner","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ero.2025.10.005_bib0041","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s00467-003-1278-y","article-title":"Lupus nephritis in childhood: a review of 53 patients followed at a single center","volume":"19","author":"Bogdanovi\u0107","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ero.2025.10.005_bib0042","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/BF00865490","article-title":"Lupus nephritis in childhood and adolescence","volume":"8","author":"Cameron","year":"1994","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ero.2025.10.005_bib0043","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000045899","article-title":"Lupus nephritis in children: prognostic significance of clinicopathological findings","volume":"87","author":"Emre","year":"2001","journal-title":"Nephron"},{"key":"10.1016\/j.ero.2025.10.005_bib0044","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1093\/ndt\/gfab152","article-title":"Long-term renal survival of paediatric patients with lupus nephritis","volume":"37","author":"Demir","year":"2022","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ero.2025.10.005_bib0045","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00467-020-04501-x","article-title":"Twelve-month outcome in juvenile proliferative lupus nephritis: results of the German registry study","volume":"35","author":"Suhlrie","year":"2020","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ero.2025.10.005_bib0046","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1177\/0961203308097570","article-title":"Outcome of lupus nephritis in Indian children","volume":"18","author":"Hari","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.ero.2025.10.005_bib0047","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1093\/ndt\/gfs589","article-title":"Lupus nephritis in children and adolescents: results of the Italian Collaborative study","volume":"28","author":"Ruggiero","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ero.2025.10.005_bib0048","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3109\/0886022X.2011.573897","article-title":"Lupus nephritis in Iranian children: a review of 60 patients","volume":"33","author":"Taheri","year":"2011","journal-title":"Ren Fail"},{"key":"10.1016\/j.ero.2025.10.005_bib0049","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1007\/s00467-006-0052-3","article-title":"Lupus nephritis in Chinese children\u2013a territory-wide cohort study in Hong Kong","volume":"21","author":"Wong","year":"2006","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ero.2025.10.005_bib0050","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2015-000123","article-title":"A proteinuria cut-off level of 0.7 g\/day after 12 months of treatment best predicts long-term renal outcome in lupus nephritis: data from the MAINTAIN Nephritis Trial","volume":"2","author":"Tamirou","year":"2015","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.ero.2025.10.005_bib0051","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.kint.2023.09.001","article-title":"Executive summary of the KDIGO 2024 Clinical Practice Guideline for the management of lupus nephritis","volume":"105","author":"Rovin","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.ero.2025.10.005_bib0052","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1097\/HJH.0b013e32832f4f6b","article-title":"Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension","volume":"27","author":"Lurbe","year":"2009","journal-title":"J Hypertens"},{"key":"10.1016\/j.ero.2025.10.005_bib0053","first-page":"332","article-title":"Renal biopsy in lupus patients with low levels of proteinuria","volume":"34","author":"Christopher-Stine","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ero.2025.10.005_bib0054","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.pedhc.2007.07.006","article-title":"Induction therapy for pediatric focal proliferative lupus nephritis: cyclophosphamide versus mycophenolate mofetil","volume":"22","author":"Lau","year":"2008","journal-title":"J Pediatr Health Care"},{"key":"10.1016\/j.ero.2025.10.005_bib0055","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/0961203319836712","article-title":"Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis","volume":"28","author":"Smith","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.ero.2025.10.005_bib0056","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/ndt\/gfu184","article-title":"To TDM or not to TDM in lupus nephritis patients treated with MMF?","volume":"30","author":"van Gelder","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ero.2025.10.005_bib0057","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00467-020-04733-x","article-title":"Mycophenolic acid area under the concentration-time curve is associated with therapeutic response in childhood-onset lupus nephritis","volume":"36","author":"Godron-Dubrasquet","year":"2021","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ero.2025.10.005_bib0058","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/bcp.12392","article-title":"Pharmacokinetics of mycophenolate mofetil in children with lupus and clinical findings in favour of therapeutic drug monitoring","volume":"78","author":"Woillard","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ero.2025.10.005_bib0059","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/FTD.0000000000000671","article-title":"Generation and validation of a limited sampling strategy to monitor mycophenolic acid exposure in children with nephrotic syndrome","volume":"41","author":"Benz","year":"2019","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.ero.2025.10.005_bib0060","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00467-009-1291-x","article-title":"The use of low-dose cyclophosphamide followed by AZA\/MMF treatment in childhood lupus nephritis","volume":"25","author":"Baskin","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ero.2025.10.005_bib0061","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/annrheumdis-2020-216924","article-title":"2019 update of the joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR\/ERA-EDTA) recommendations for the management of lupus nephritis","volume":"79","author":"Fanouriakis","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"suppl 10","key":"10.1016\/j.ero.2025.10.005_bib0062","article-title":"A phase II randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of obinutuzumab or placebo in combination with mycophenolate mofetil in patients with active class III or IV lupus nephritis [abstract]","volume":"71","author":"Furie","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ero.2025.10.005_bib0063","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.2215\/CJN.01070118","article-title":"Peripheral blood B cell depletion after rituximab and complete response in lupus nephritis","volume":"13","author":"Gomez Mendez","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ero.2025.10.005_bib0064","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/0002-9343(77)90345-X","article-title":"Lupus nephritis. Clinical course as related to morphologic forms and their transitions","volume":"62","author":"Baldwin","year":"1977","journal-title":"Am J Med"},{"key":"10.1016\/j.ero.2025.10.005_bib0065","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11560-021-00519-w","article-title":"Systemischer Lupus erythematodes: was ist neu?","volume":"16","author":"Boedecker-Lips","year":"2021","journal-title":"Nephrol"},{"key":"10.1016\/j.ero.2025.10.005_bib0066","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11560-021-00525-y","article-title":"Blockierung des renin-angiotensin-aldosteron-systems: einfluss auf die progression der chronischen nierenerkrankung [Inhibition of the renin-angiotensin-aldosterone system]","volume":"17","author":"Schmitt","year":"2022","journal-title":"Nephrologe"},{"key":"10.1016\/j.ero.2025.10.005_bib0067","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1097\/HJH.0000000000001039","article-title":"2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents","volume":"34","author":"Lurbe","year":"2016","journal-title":"J Hypertens"},{"key":"10.1016\/j.ero.2025.10.005_bib0068","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s00467-020-04519-1","article-title":"IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome","volume":"35","author":"Trautmann","year":"2020","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ero.2025.10.005_bib0069","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ero.2025.10.005_bib0070","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/ard-2023-224609","article-title":"2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"82","author":"Barbhaiya","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ero.2025.10.005_bib0071","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.autrev.2010.08.005","article-title":"Catastrophic antiphospholipid syndrome: updated diagnostic algorithms","volume":"10","author":"Erkan","year":"2010","journal-title":"Autoimmun Rev"}],"container-title":["EULAR Rheumatology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050708125000953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050708125000953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T21:12:42Z","timestamp":1766005962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3050708125000953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":71,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S3050708125000953"],"URL":"https:\/\/doi.org\/10.1016\/j.ero.2025.10.005","relation":{},"ISSN":["3050-7081"],"issn-type":[{"value":"3050-7081","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interdisciplinary Clinical Practice Guidelines for patient-centred management of juvenile-onset systemic lupus erythematosus","name":"articletitle","label":"Article Title"},{"value":"EULAR Rheumatology Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ero.2025.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}]}}